Ornidyl, Vaniqa (eflornithine) is a small molecule pharmaceutical. Eflornithine was first approved as Ornidyl on 1990-11-28. It is used to treat african trypanosomiasis, hypertrichosis, and protozoan infections in the USA. It has been approved in Europe to treat hirsutism. The pharmaceutical is active against ornithine decarboxylase.
|Indication||african trypanosomiasis, hirsutism, hypertrichosis, protozoan infections|
|Drug Class||Fc fusion protein|